Patent No:
National Invention Patent for Patented Strain and Production Method of Vitamin K2 (MK-7)
A Bacillus Subtilis Natto and a Method for Producing MK-2
(Patent NO.ZL 2019 1 0593690.9)
Description:
Vitamin K2 contributes to bone and cardiovascular health. There are two vitamin K2 homologues, menaquinone-4 (MK-4) and menaquinone-7 (MK-7), that have been used as nutrients by the food industry and as nutritional supplements to support bone and cardiovascular health.
MK-4 is a shorter-chain of menaquinone, primarily found in animal products; whilst, MK-7 is a long-chain menaquinone found in natto, a traditional Japanese fermented soy food. MK-7 is generally considered more bioavailable and has a longer half-life in the body compared to MK-4.
Purity and Quality:
Natural Vitamin K2 produced by SungenBio is 100% all trans Vitamin K2 (MK-7) with the highest activity and a very high affinity for the human body. The internal control index is higher than ESP 39-NF34 standard. The ratio of trans vitamin K2 (MK-7) is ≥ 98%
Clinical Study:
Liver Health
A study “Role of Vitamin K2 in the Development of Hepatocellular carcinoma in women with viral cirrhosis of the liver” shows that vitamin K2 treatment enhances liver regeneration, which is associated with matrillin-2 mRNA expression and matrillin-2 up regulation. The vitamin K2 actions can effectively inhibit the growth of liver cancer cells and decrease the risk of liver cancer by 20%.
- Fermented from Natto by Bacillus subtilis, green and safe
- High activity strains induced by modern biotechnology
- Reasonable culture formula, multi facto dynamic control technology
- Physical separation and concentration technology without organic solvents
- No preservatives. No additives. No chemical substances. Solvent Free
- Stable and Durable bioactivity
| Product Form | Oil, Powder, Water Soluble Powder, Powder suitable for alkaline |
| Description | Vitamin K2 (MK-7) fermented from Natto by Bacillus subtilis |
| Recommended Dose | microgram / per day |
